Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054275
Status:
COMPLETED
Last Update Posted:
2016-02-17
First Post:
2003-02-05
Brief Title:
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Sponsor:
Organization:
Case Comprehensive Cancer Center